Streetbeat News

Price Targets

BSX

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Boston Scientific (NYSE:BSX) and increased the price target from $59 to $62.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:16 pm

DXCM

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on DexCom (NASDAQ:DXCM) and increased the price target from $110 to $136.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:15 pm

FCX

UBS analyst Andreas Bokkenheuser has maintained a Neutral rating on Freeport-McMoRan (NYSE:FCX) and reduced the price target from $42 to $41.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:14 pm

ABT

Wells Fargo analyst Lawrence Biegelsen has maintained an Overweight rating on Abbott Laboratories (NYSE:ABT) and increased the price target from $116 to $121.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:13 pm

TMUS

UBS analyst John Hodulik has maintained a Buy rating on T-Mobile US (NASDAQ:TMUS) and increased the price target from $180 to $186, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:13 pm

PRCT

Wells Fargo analyst Nathan Treybeck has maintained an Overweight rating on PROCEPT BioRobotics (NASDAQ:PRCT) and increased the price target from $40 to $44.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:12 pm

PB

UBS analyst Brody Preston has reaffirmed a Buy rating on Prosperity Bancshares (NYSE:PB) and increased the price target from $65 to $71, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:10 pm

T

Wells Fargo analyst Eric Luebchow has maintained an Overweight rating on AT&T (NYSE:T) and increased the price target from $17 to $20.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:09 pm

GLOB

UBS analyst Leonardo Olmos has maintained a Neutral rating on Globant (NYSE:GLOB) and increased the price target from $210 to $230.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:08 pm

TMUS

Wells Fargo analyst Eric Luebchow has maintained an Overweight rating on T-Mobile US (NASDAQ:TMUS) and increased the price target from $170 to $175.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:07 pm